Is there a generic for Dimyristoyl lecithin; perflexane?

The FDA Orange Book does not currently list an approved generic (ANDA) for Dimyristoyl lecithin; perflexane. It is available as 1 brand (NDA) application.

What is the reference-listed drug for Dimyristoyl lecithin; perflexane?

IMAGENT (NDA 021191, VESSELON SPV LLC) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Dimyristoyl lecithin; perflexane are approved?

Dimyristoyl lecithin; perflexane is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Dimyristoyl lecithin; perflexane

Dimyristoyl lecithin; perflexane is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:IMAGENT · NDA 021191

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
IMAGENT	VESSELON SPV LLC	NDA 021191	—	May 31, 2002

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Dimyristoyl lecithin; perflexane — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo